MedMira (MedMira) EV-to-EBIT : -39.17 (As of May. 22, 2024)

View and export this data going back to . Start your Free Trial

What is MedMira EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, MedMira's Enterprise Value is $54.88 Mil. MedMira's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was $-1.40 Mil. Therefore, MedMira's EV-to-EBIT for today is -39.17.

The historical rank and industry rank for MedMira's EV-to-EBIT or its related term are showing as below:

MMIRF' s EV-to-EBIT Range Over the Past 10 Years
Min: -10009.34 Med: -10.93 Max: 7173.56
Current: -39.59

During the past 13 years, the highest EV-to-EBIT of MedMira was 7173.56. The lowest was -10009.34. And the median was -10.93.

MMIRF's EV-to-EBIT is ranked worse than
100% of 427 companies
in the Biotechnology industry
Industry Median: 10.09 vs MMIRF: -39.59

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. MedMira's Enterprise Value for the quarter that ended in Jan. 2024 was $30.58 Mil. MedMira's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was $-1.40 Mil. MedMira's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was -4.58%.

MedMira EV-to-EBIT Historical Data

The historical data trend for MedMira's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMira EV-to-EBIT Chart

MedMira Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

EV-to-EBIT

Get a 7-Day Free Trial

-11.65

-218.20

-3,952.18

-74.57

-38.29

MedMira Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EV-to-EBIT	Get a 7-Day Free Trial															-60.77	-44.07	-38.29	-35.80	-37.73

Competitive Comparison of MedMira's EV-to-EBIT

For the Biotechnology subindustry, MedMira's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedMira's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MedMira's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MedMira's EV-to-EBIT falls into.

MedMira EV-to-EBIT Calculation

MedMira's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	54.875	/	-1.401
	=	-39.17

MedMira's current Enterprise Value is $54.88 Mil.
MedMira's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.40 Mil.

MedMira (OTCPK:MMIRF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

MedMira's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jan. 2024 )	=	EBIT	/	Enterprise Value (Q: Jan. 2024 )
	=	-1.401	/	30.577585
	=	-4.58 %

MedMira's Enterprise Value for the quarter that ended in Jan. 2024 was $30.58 Mil.
MedMira's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.40 Mil.

MedMira EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of MedMira's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMira (MedMira) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (OTCPK:MMIRF) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

47M:Germany MIR:Canada

Address

155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3

Website

https://www.medmira.com

MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.